Objective: To review a 2-institution experience with minimally invasive mitral valve surgery over a 12-year period.
Because of excellent clinical results, minimally invasive mitral valve surgery (MIMVS) has evolved since the mid1990s and has become the preferred method of mitral valve repair (MVP) and mitral valve replacement (MVR) at certain specialized centers worldwide. MIMVS refers to a collection of new techniques and operation-specific technologies, such as modified perfusion methods and visualization techniques that are directed toward minimizing surgical trauma. The belief that this approach leads to less pain, shorter hospital stays, faster return to normal activities, superior cosmesis, and potential cost savings has driven this development. 1, 2 However, some surgeons still express concern that restricted exposure, limited operating space, and longer instruments may lead to inferior results both in ability to repair the valve and long-term outcomes. 3 Since 1996, surgeons at East Carolina University and the University of Pennsylvania have had a large experience with video-assisted mitral valve surgery through a 4-cm right minithoracotomy. The aim of this study was to review our collective early results and to examine the safety, efficacy, and early outcomes of MIMVS.
METHODS Patients
We prospectively collected pre-, intra-, and postoperative data on all patients who had video-assisted mitral valve surgery at East Carolina University between May 1996 and April 2008 and the University of Pennsylvania between November 1998 and October 2007. During this period, all patients referred with mitral valvular disease were considered for video-assisted mitral valve surgery. Absolute contraindications to this approach included severe peripheral vascular disease, a history of a prior right-sided thoracotomy/irradiation, concomitant coronary artery disease requiring surgical revascularization, or concomitant aortic valvular disease requiring replacement. As this was our standard approach, Institutional Review Board approval was not needed, but standard informed consent regarding surgical approach and expected outcomes was obtained by either the operating surgeon or team. Patients having robotic mitral valve surgery using the da Vinci Ò system (Intuitive Surgical Inc, Mountain View, Calif) were excluded from this analysis.
Surgical Technique
Our surgical approach has been described previously 4, 5 and is summarized here. Each operation was performed through a 4-cm working incision made in the right infrathoracic groove and carried through the fourth intercostal space. Rib spreading was limited by using small thoracic and soft tissue retractors. Each patient had double-lumen endotracheal intubation followed by a transesophageal echocardiography study. To minimize intracardiac air retention, the pleural cavity was flooded continuously with CO 2 .
Vacuum-assisted femoral-femoral cardiopulmonary bypass (CPB) was used with upper-body venous return augmented through a 15F to 17F right internal jugular cannula positioned in the superior vena cava. For primary procedures, aortic occlusion was accomplished by either transthoracic clamping (TTC) or endoaortic balloon occlusion (EABO), according to surgeon preference. For reoperative cases, either hypothermic fibrillation (HF) or EABO was used. Hypothermic (28 C) perfusion and cold (4 C-6 C) antegrade cardioplegic solution, administered at 15-to 20-minute intervals, were used for systemic and myocardial protection. When necessary, retrograde cardioplegic solution was administered through a transjugular or transthoracic coronary sinus catheter. Long-shafted instruments were used to perform each operation (Geister, Plymouth, Mass).
Operative visualization was through a 5-mm endoscope, passed through an anterior axillary line fourth intercostal space trocar. A left atriotomy (Waterston's interatrial groove) was made, and MVPs were done using standard Carpentier techniques. Posterior, anterior, and bileaflet prolapsing valves were repaired in this series. MVR was performed with interrupted pledgetted 2-0 Ticron (Tyco Healthcare, Mansfield, Mass) mattress sutures using both biologic and mechanical valves. Cardiac deairing was performed by flushing the left atrium across the atrial suture line as well as aortic root venting. Echocardiography ensured intracardiac air removal and was used to monitor valve and ventricular function.
Statistical Analysis
Descriptive statistics were reported using means AE standard deviations, medians AE interquartile ranges (IQRs), and proportions. Comparisons of data between groups were carried out using either a 2-sided t test or the Kruskal-Wallis test for continuous data and c 2 or Fisher exact test for categorical data. A nonparsimonious, multivariate logistic regression model was constructed on the basis of pre-and intraoperative variables to determine predictors of in-hospital mortality with the odds ratio (OR) of each predictor serving to quantify its relative effect on mortality. A C-statistic for the model was generated to assess the ability to discriminate between patients with the adverse outcome of interest and those without any. All analyses were performed using SAS version 9.1.3 (SAS Institute, Cary, NC).
RESULTS
A total of 1178 patients had a minimally invasive mitral valve procedure (University of Pennsylvania, 634; East Carolina University, 544 (Table 2) . Concomitant procedures were performed in 390 patients (33.1%) and included atrial fibrillation (AF) ablation in 265 patients (22.5%), tricuspid valve surgery in 64 patients (5.4%), patent foramen ovale/atrial septal defect closure in 111 patients (9.4%), and oversewing of the left atrial appendage in 114 patients (9.7%).
The transthoracic clamp was used in 573 patients (48.7%), EABO in 479 patients (40.7%), HF in 120 (10.1%), and TTC þ HF in 6 (0.5%). Compared with TTC, prior cardiac surgery was more common and operative times were longer with EABO but the rate of valve repair was similar (Table 3 ). The incidence of stroke with EABO was 2.7% versus 1.2% with TTC (P ¼ .08). There were 7 aortic dissections (1.5%) with the endoballoon (type A, n ¼ 4; type B, n ¼ 3) and 2 (0.4%) with the transthoracic clamp (type A, n ¼ 2; P ¼ .09). All patients with a type B dissection survived without neurologic deficit, whereas 2 of those with type A dissection died (mortality 33%) and 1 further patient had a stroke. There was a significantly higher rate of conversion to sternotomy and longer hospital stay with EABO although no significant difference in mortality.
Among patients having an MVP, repair techniques included a ring annuloplasty in 924 patients (98.2%) with a median ring size of 30 mm (IQR 28-34 mm), Carpentier-type leaflet resection in 383 patients (40.7%), sliding plasty in 198 patients (21.0%), chordal transfer in 85 patients (9.0%), and polytetrafluoroethylene neochordae placement in 70 patients (7.4%; Table 4 ). The intraoperative transesophageal echocardiogram demonstrated that 97.1% of patients having MVP for MR left the operating room with no more than trivial residual MR (Table 5 ). In patients having MVR, a bioprosthesis was placed in 101 (42.6%) and a mechanical valve in 136 (57.4%).
Nineteen patients (1.6%) had intraoperative conversion to sternotomy (MVR 6, MVP 13), the reasons being: type A aortic dissection (n ¼ 6), atrioventricular groove disruption (n ¼ 6), circumflex artery injury (n ¼ 2), severe mitral annular calcification (n ¼ 1), contralateral tension pneumothorax (n ¼ 1), aortoinnominate junction injury (n ¼ 1), difficult aortic occlusion (n ¼ 1), and other (n ¼ 1).
Postoperative and Midterm Outcomes
Overall operative mortalities for MVP and MVR were 2.1% and 4.6%, respectively. Mortalities for isolated MVP and MVR were 0.8% and 3.9% and for isolated primary MVP and MVR were 0.2% and 3.6%, respectively.
Reoperation for bleeding was required in 63 patients (5.4%), with the same video-assisted approach used in all patients without the need for conversion to sternotomy. Postoperative strokes were observed in 23 patients (2.0%). Median hospital stay was 6 days (IQR 5-8 days). Other complications are shown in Table 6 . Twenty-two patients (1.9%) had a reoperation at a mean of 732 AE 1014 days as the result of either recurrent severe MR (n ¼ 13), endocarditis (n ¼ 3), recurrent severe MS (n ¼ 2), valve dehiscence (n ¼ 2), systolic anterior motion (n ¼ 1), or hemolysis (n ¼ 1).
Multivariate logistic regression modeling revealed that New York Heart Association functional class III/IV, diabetes, CPB time>180 minutes, preoperative AF, and age>70 years were independent predictors of mortality, whereas previous cardiac surgery was not ( Table 7 ). The C-statistic of the model was 0.86.
DISCUSSION
This series comprises our total experience, including our learning curve, of minimally invasive video-assisted mitral valve surgery from May 1996 until May 2008. The in-hospital mortalities of 0.8% and 3.9% for isolated MVP and MVR, respectively, are lower than the reported operative mortality rates in the Society of Thoracic Surgeons Fall 2007 report (1.6% and 6.1%, respectively). 6 The mortality figures in our series are also concordant with other reports of the same technique ranging from 0.4% to 2.4% for MVP and from 2.5% to 5.8% for MVR.
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Critics of MIMVS suggest that MVP may be performed less frequently and that the repair may be less durable than that obtained through a sternotomy. The greater degree of difficulty presented by limited operating space, long instruments, and video assistance are cited as reasons for this opinion. 7 Overall, 79.9% of our patients had a repair; however, of those having a repair for MR, our repair rate was 86.6%. This is similar to the series reported by Seeburger and colleagues 7 (1536 patients, 87.2%), Aybek and associates
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(241 patients, 83%), Casselman and coworkers 8 (306 patients, 74%), and Grossi's group 9 (561 patients, 66.8%), using the right minithoracotomy approach; and Mihaljevic and colleagues 12 (474 patients, 88%), using the lower hemisternotomy; or Suri and associates 13 (1411 patients, 83%), using a median sternotomy. This clearly demonstrates that this technique is reproducible with repair rates comparable to both conventional surgery and other minimally invasive approaches with over 97% of patients leaving the operating room with no more than trivial residual regurgitation. Thus, the early results of repair are clearly not compromised by this less invasive approach. In terms of durability, a reoperative rate of 1.9% at just over 2 years is consistent with published sternotomy repair data. The increased operative risk associated with advanced age is ubiquitous in surgical articles 14 ; however, the importance of a reoperative sternotomy has been deemphasized. [15] [16] [17] In a multivariate logistic regression model of 409,904 valve procedures performed between 1994 and 2003 and cataloged in the Society of Thoracic Surgeons database, the third most important preoperative variable influencing operative mortality was a reoperation (OR 1.61, P<.001).
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18 However, our data suggest that a right minithoracotomy approach after previous median sternotomy is not an independent predictor of mortality (OR 1.13, P ¼ .77). This important finding suggests that, in terms of early outcomes, this should be the technique of choice for reoperative mitral valve surgery in patients who do not need a concomitant aortic valve replacement or coronary revascularization. This is concordant with data demonstrating equivalent or lower mortality rates and less morbidity for a right minithoracotomy approach versus a reoperative sternotomy. [19] [20] [21] However, data on mid-and long-term outcomes are needed.
Patients with AF frequently present with more severe symptoms with increased cardiac morbidity in the form of a prior myocardial infarction, cardiomegaly, tricuspid valve regurgitation, and/or pulmonary hypertension. Prior nonsurgical series have identified AF as a marker of severe cardiac disease and a specific risk factor for decreased long-term survival. 22, 23 Moreover, numerous surgical series have documented poorer long-term outcomes in patients with AF having mitral valve, [24] [25] [26] [27] coronary, 28 or aortic valve surgery. 29 The influence on both short-term outcomes and operative mortality has hitherto been less clear. Both Lim and associates 25 and Chua and colleagues 30 demonstrated no difference in operative mortality for patients with AF versus those who are in sinus rhythm having MVP. 25, 30 A more recently published study of 2821 Mayo Clinic patients documents higher operative mortality for AF patients, 24 data that are supported by Alexiou and colleagues. 26 However, differences in baseline characteristics between patients with/without AF may have confounded these results. Our data, in a multivariate logistic regression model, clearly demonstrate that preoperative AF is an independent predictor of operative mortality following MIMVS. This strengthens the argument for early operative intervention in mitral valve disease prior to the development of AF.
Aortic dissection associated with a minimally invasive approach may occur either at the site of aortic occlusion, be it endoaortic or transthoracic, or from the femoral cannulation site through retrograde malperfusion. Although the incidence of dissection and strokes was higher with EABO in our series, these differences were not statistically significant. In the first Port Access International Registry (PAIR) report, the incidence of aortic dissection was 1.3% in the first half of the study compared with 0.2% in the second half, a difference attributable to experience, better techniques, and improved technology particularly balloon design. 10 Grossi and colleagues, 9 Casselman and associates, 8 and Onnasch and coworkers 31 reported dissection rates of 0.3% (2/714), 0.7% (2/306), and 1.4% (3/209) with EABO, and the latter also reported a significantly higher incidence of neurologic complications with EABO compared with the transthoracic clamp. These concerns led the authors to abandon EABO for primary mitral valve procedures. 31 Although, operative times are longer with EABO, a finding that has been mirrored by other smaller studies, 32, 33 this does not have a negative influence on the valve repair rate. These studies also demonstrated fewer technical difficulties and complications, less blood loss, and lower costs using the transthoracic clamp. Our data also demonstrate a longer postoperative stay with EABO. However, as EABO is predominantly used at 1 center, differing institutional practices may be a confounding variable.
Aortic dissection and atrioventricular groove disruption were the commonest reasons for conversion to sternotomy in our series, which occurred in 1.6% of patients. Conversion to median sternotomy generally occurs infrequently during the right minithoracotomy approach and others have reported this in 0.3%, 7 1.1%, 9 and 2.0% 8 of patients. For the upper-hemisternotomy approach, this complication has been reported in 2.4% to 2.6% of patients, mostly due to bleeding, refractory arrhythmias, or ventricular dysfunction, whereas for the lower-hemisternotomy approach, this occurred in 4.0% of patients, most commonly due to poor exposure. 34, 35 A reduction in postoperative hemorrhage, transfusion requirements, and need for reexploration for bleeding have been suggested as potential advantages of minimally invasive valve surgery due to a reduction in surgical trauma. This benefit is important given the significant morbidity and mortality associated with transfusions and reexploration. 36 Our data show that 45.5% of patients needed transfusion of blood or blood products (MVP 40.7%, MVR 64.6%). Reexploration for bleeding occurred in 5.4% of patients; other similar studies have reported this in 4.9%, 9 5.1%, 7 and 8.5% of patients. 8 The STS database between 1994 and 2003 reported this in 5.5% of all valvar procedures. 18 A recently reported meta-analysis of MIMVS did, however, suggest a significantly reduced need for reoperation for bleeding compared with median sternotomy. 37 In the majority of cases, the source of bleeding was from the chest wall and, in all cases, reexploration was accomplished safely through the original minithoracotomy incision without the need for conversion to sternotomy. From a technical aspect, we have found a 30 videoscope and dental mirror useful adjuncts for assessing chest wall hemostasis.
In summary, video-assisted MIMVS is safe and associated with a high rate of repair, low perioperative morbidity, and excellent early echocardiographic results. When compared with the transthoracic clamp, the EABO technique had a higher incidence of aortic dissection and strokes, although these differences did not reach statistical significance. Reoperative surgery, after a previous median sternotomy, was not an independent predictor for mortality, suggesting that the minithoracotomy approach may be superior to sternotomy in terms of early outcomes. Preoperative AF was an independent predictor of mortality, demonstrating that operative risk is increased if surgery is delayed until the onset of AF.
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